Don DeGolyer

Don DeGolyer is a well-known figure in the healthcare investment sector, with a proven track record in biopharmaceuticals, managed care, and technology-enabled healthcare.

Currently, Don holds the role of Senior Advisor at Koch Strategic Platforms, a growth equity investment subsidiary of Koch Industries, where he focuses on late-stage venture and growth equity investments in Healthcare IT, Healthcare Services, and Life Science Tools & Services.

Don is actively involved in various board director positions, including Vertice Pharma, a private specialty pharmaceutical company he founded, HLS Therapeutics, a commercial stage CNS/Cardiovascular specialty pharmaceutical company, and TYME Technologies, a development stage cancer company.

In addition to his corporate roles, Don is dedicated to philanthropic work, serving on the board of directors for Make-A-Wish New Jersey and founding the Strong Women Foundation, a non-profit organization aimed at supporting single mothers and their children.

Don's educational background includes a Bachelor's degree from the University of Rochester and a Master of Business Administration (MBA) in Marketing Management from Fairleigh Dickinson University-Florham Campus.

Throughout his career, Don has held various significant positions in renowned organizations, such as Chief Operating Officer at Endo International plc, CEO at Sandoz Inc. (a Novartis company), and SVP of Managed Care & Established Products at Novartis.

Don's expertise also extends to executive roles, including President of Global Therapeutics & Board Director at Oxford GlycoSciences, Executive Vice President & Chief Commercial Officer at ParkStone Medical, Vice President Pharma at Johnson & Johnson, and Sales Management at Pfizer.